ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.
Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback